logo
How to Limit Medical Debt's Impact on Your Credit

How to Limit Medical Debt's Impact on Your Credit

Yahoo17-07-2025
Planning Medical expenses Credit - Getty Images
For the millions of Americans struggling to pay off the costs of expensive medical procedures, the looming debt is accompanied by another threat: that the unpaid medical bills could drag down their credit scores, making it harder to get a credit card or buy a home or car. And now a rule that would have addressed that issue will no longer be going into effect.
In the final days of President Joe Biden's term, the Consumer Financial Protection Bureau (CFPB) issued a rule that would have removed medical debt from credit reports. The goal was to 'reduce the burden of medical debt and ensure that patients are not denied access to credit for home mortgages, car loans, or small business loans due to unpaid medical bills,' according to the White House press release at the time. But under the Trump Administration, the CFPB flipped its stance on the rule, which had not yet gone into effect. And on Friday, a federal judge, who was appointed by President Donald Trump, vacated the rule, stating that it exceeded the CFPB's authority under the Fair Credit Reporting Act.
Roughly $88 billion of unpaid medical bills are in collections across the U.S., according to the CFPB, which estimates that the issue affects about one in five Americans.
JoAnn Volk, a research professor and co-director of the Center on Health Insurance Reforms at Georgetown University, says the judge's ruling 'eliminates an important protection for families who are going to be shut out of credit because of this medical debt that they could not avoid.'
How medical debt impacts credit
CFPB research has indicated that medical debt on credit reports is 'a poor predictor' of whether a person will repay a loan, but still 'contributes to thousands of denied applications on mortgages that consumers would be able to repay,' the agency said at the time the Biden-era rule was finalized.
'We know from prior studies that medical debt does not have meaningful predictive power for people's credit worthiness. Part of the reason is that medical debt, more than any other form of debt, is the result of bad luck, not bad financial behavior,' says Neale Mahoney, an economics professor at Stanford University and director of the Stanford Institute for Economic Policy Research. 'Nobody plans to go to the hospital or have a kid slip and fall and need to be rushed to the ER and have to pay those medical bills; that is just bad luck.'
The Biden-era rule would have led to the approval of about 22,000 additional, affordable mortgages annually, and the credit scores of people with medical debt on their credit reports would increase by an average of 20 points, the CFPB estimated. Mahoney says vacating it will reduce credit access for people struggling with medical debt.
There are some steps that can be taken to mitigate that impact—though they're limited.
Financial assistance options
Mahoney advises people who find themselves faced with burdensome medical bills to first take advantage of their hospital's or physician's financial assistance program. Many hospitals have such programs, which are often listed on the back of the bill, that can reduce or sometimes even eliminate the cost depending on a patient's income or assets.
'It can be a slog to work through the process, but for many people, addressing the issue with the hospital is better than letting that issue fester and then become a medical debt with a debt collector,' Mahoney says. There are some organizations, like Dollar For, that help patients navigate these financial assistance programs.
The CFPB offers some general tips for people dealing with medical debt, such as confirming the unpaid bill with the appropriate source, contacting their insurer if they believe the service should have been covered, and disputing any errors in the bill or credit report.
Debt payment plans
If a person's debt has been sold to a debt collector and they're concerned about its potential impact on their credit score, Mahoney recommends that they try and negotiate a payment plan with the debt collection company.
Sometimes, a debt collector may be open to receiving a payment that is more within reach for the patient and, in turn, removing that debt from the credit report, he says.
Contact us at letters@time.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pitney Bowes Inc (PBI) Q2 2025 Earnings Call Highlights: Strategic Moves and Financial ...
Pitney Bowes Inc (PBI) Q2 2025 Earnings Call Highlights: Strategic Moves and Financial ...

Yahoo

time21 minutes ago

  • Yahoo

Pitney Bowes Inc (PBI) Q2 2025 Earnings Call Highlights: Strategic Moves and Financial ...

Share Repurchase Authorization: Increased to $400 million. Dividend Increase: $0.01 increase for the third consecutive quarter. Free Cash Flow Guidance: Reiterated for the full year. Revenue Guidance: Reduced by $50 million. EBIT Margin Guidance: Tightened by reducing the high end of the range. EPS Guidance: Increased by $0.10. Adjusted Leverage Ratio: Now below 3x. Warning! GuruFocus has detected 4 Warning Sign with PBI. Release Date: July 30, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Pitney Bowes Inc (NYSE:PBI) reported significant earnings and cash flow growth on a year-over-year basis. The company nearly exhausted its $150 million share repurchase authorization and increased its dividend for the third consecutive quarter. The Board increased the share repurchase authorization to $400 million, reflecting confidence in the company's financial position. The company has a strong free cash flow and liquidity position, with an adjusted leverage ratio now below 3x. The SaaS business within SendTech showed strong performance, with a 17% year-over-year growth for the quarter. Negative Points Pitney Bowes Inc (NYSE:PBI) reduced its revenue guidance range by $50 million due to customer losses in the Presort business. The company tightened its EBIT margin range by bringing down the high end of the range. The reduction in revenue guidance was attributed to previous management decisions not to offer price concessions to at-risk Presort customers. The Presort business has not yet reversed customer losses, impacting revenue and EBIT guidance. The overall shipping revenue was down 2.5% year-over-year for the quarter due to declines in the non-core part of the business. Q & A Highlights Q: With the new share repurchase authorization, do you intend to continue buybacks in 2025, or will you wait to see how the business performs? A: Kurt Wolf, CEO: We can't comment on future market activities, but our historical share purchases reflect where we see value in the company. Our incentive structure, with options at strike prices of $12, $14, and $16, indicates our valuation perspective. With our leverage ratio below 3.0, we have increased access to restricted payments, providing flexibility for future buybacks. Q: Does the appointment of a new CFO change the timing of the strategic review? A: Kurt Wolf, CEO: The new CFO, Paul Evans, accelerates rather than delays the review. We are conducting a thorough internal review, identifying numerous opportunities for shareholder value creation. The internal review will likely continue through 2025, with a more comprehensive review starting in 2026. Q: How is the shipping subsegment within SendTech performing, and what is the outlook for the rest of the year? A: Kurt Wolf, CEO: The overall shipping revenue was down 2.5% year-over-year due to declines in non-core business. However, core shipping grew by 6%. The SaaS business within shipping grew by 17% year-over-year, and we expect it to continue outpacing core shipping revenue. Q: Are there any structural weaknesses in the Presort business following recent customer losses? A: Kurt Wolf, CEO: The reduction in revenue guidance is largely due to competitive losses in Presort, which were avoidable. We believe Presort and SendTech are strong businesses with high profitability and competitive capabilities. We are working to regain lost customers and capture new ones, leveraging our position as a low-cost provider. Q: How do you view the potential for refinancing bonds, given the current high-yield market conditions? A: Paul Evans, CFO: We are considering refinancing options, balancing our debt's average life and coupon rates. We have the liquidity to pay off the 2027 notes, but we will evaluate the best timing and approach based on market conditions and our strategic needs. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Factbox-Trump tariffs threaten India's export edge; key sectors brace for impact
Factbox-Trump tariffs threaten India's export edge; key sectors brace for impact

Yahoo

time21 minutes ago

  • Yahoo

Factbox-Trump tariffs threaten India's export edge; key sectors brace for impact

By Vivek Kumar M and Bharath Rajeswaran (Reuters) -U.S. President Donald Trump on Wednesday slapped 25% tariffs on Indian goods, along with an unspecified penalty tied to energy and defence purchases from Russia — a move that, if enforced, could erode India's export competitiveness and weigh on investor sentiment. India's trade surplus with the U.S. — its largest export market — stood at 1.2% of GDP in 2024. Analysts warn halving that surplus could shave 25–40 basis points off GDP, undermining India's 'safe haven' narrative amid a global slowdown. The relative appeal of Indian markets has also faded, with local equities underperforming peers like Vietnam and Indonesia, which have secured trade pacts with Washington. CLSA said the tariff threat adds to uncertainty in an already expensive market. With negotiations set to resume in mid-August, markets expect the final tariff rate to be lower than 25%. But until clarity emerges, export-linked sectors face significant near-term headwinds. See below for a sector snapshot on who is exposed: PHARMACEUTICALS The U.S. accounts for nearly one-third of India's pharma exports (about $9 billion in FY24). Jefferies estimates a 2–8% EPS hit for Biocon, Sun Pharma and Dr. Reddy's, if generics are included. HSBC warns of an up to 17% downside to FY26 earnings forecasts. TEXTILES Exporters like Welspun Living, Gokaldas Exports, Indo Count and Trident derive 40–70% of sales from the U.S. Higher tariffs could shift market share to Vietnam, which benefits from lower U.S. duties. OIL REFINING A proposed penalty on Russian oil imports could hit Reliance Industries and state-run refiners Bharat Petroleum and Hindustan Petroleum. Companies may face higher costs if forced to diversify crude sourcing. AUTO COMPONENTS Automakers have limited U.S. exposure, but parts makers including Bharat Forge and Sona BLW are Motors' Jaguar Land Rover unit is shielded under U.S.-UK/EU trade arrangements. CAPITAL GOODS & CHEMICALS Cummins India, Thermax and KEI Industries have 5–15% U.S. exposure. Chemical exporters such as Navin Fluorine, PI Industries and SRF may face margin pressure, especially on refrigerant gas exports. SOLAR EQUIPMENT Waaree Energies and Premier Energies count the U.S. as a key market. Nearly 20% of Waaree's FY24 revenue came from the U.S., which also accounts for a major chunk of its 59% overseas current order book. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Editorial: Hands off — Trump's off-base attack on NYC's sanctuary immigration policy
Editorial: Hands off — Trump's off-base attack on NYC's sanctuary immigration policy

Yahoo

time21 minutes ago

  • Yahoo

Editorial: Hands off — Trump's off-base attack on NYC's sanctuary immigration policy

Intentionally misstating New York City's sanctuary immigration policy as thwarting the prosecution of violent criminals, the Trump administration continued its war on local government by filing suit in federal court last week, one of a number of similar lawsuits across the country that conflate civil noncooperation with active criminal interference and attempt to conscript local officials into President Donald Trump's destructive crackdown. This should prove to Mayor Mayor Adams and other state and city leaders that no amount of appeasement is going to forestall the targeting from Trump. Adams met multiple times with immigration coordinator Tom Homan, insisting that the two men had 'the same goal,' making concessions like signing off on the opening up of an ICE office on Rikers Island years after a city sanctuary law had kicked them out. It's clear that Trump and Homan were not and probably could not be placated to the extent that they would leave Adams and New York City alone. The reality is that this is a totalizing project; Stephen Miller and the rest of the White House want to rid the country almost entirely of immigrants, with or without legal status, and regardless of where they are or what effect that will have on our economy and society. They've been routinely violating the law to do so. It's worth noting once more that Trump's is a political movement that often proclaimed itself a defender of state rights and local control, but apparently that only extended to allowing local officials to detain immigrants, pull books from school shelves, limit access to abortion, curb labor and environmental protections and drive LGBTQ people from public life. When it comes to a refusal to participate in federal operations that have so far involved masked and unidentified agents shoving people into unmarked vehicles — just the sort of thing that we would call authoritarianism and tyranny anywhere else — then states and localities get no say beyond being extensions of a central government. We're not particularly worried that any competent judge would accept these nonsensical claims. A day after the New York case was filed, a federal judge in Chicago dismissed the Trump lawsuit against that city's sanctuary immigration policy. We just want to remind readers that sanctuary is not immunity from prosecution, especially prosecution for violent crimes. What it is however is that when someone is treated at a city health clinic for TB or enrolls a child in school or reports a crime to the police as a victim or a witness, the person's civil immigration status is irrelevant. We want everyone in the city to get treated when sick, we want all children to be in school, we want all crime victims and witnesses to come forward to the cops. The idea of anti-commandeering — the notion that the federal government can't force state and local governments to carry out its own agenda and enforcement functions — has been foundational from the genesis of our country's federalized system. The right of jurisdictions to enact sanctuary provisions that block the use of local resources for this federal function has been litigated over and over again, and always found to be on solid legal footing. We are, however, more worried about the U.S. Supreme Court, which has in the past several months taken it upon itself to sign off on Trump's expansive power grabs. It has allowed among other things Trump to fire federal employees and independent agency members in direct contravention of statute, allowed the limiting of a nationwide order blocking Trump's attempt to overturn the 14th Amendment's birthright citizenship provisions and allowed parents to impose religious beliefs on whole school curricula. If these questions get up to that high court level, we hope that the justices will exercise some of their independent power, as they did on other absolutely egregious instances like Trump's efforts to remove people without due process under the Alien Enemies Act proclamation. Anything else will destroy the trust of people in their own local officials and governments and strike at the very foundation of this country's system of government. _____

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store